Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar

Journal of Immunology Research

Volumn 2019, Issue , 2019, Pages

  Al Kahlout, Reham A ^a   Nasrallah, Gheyath K ^a   Farag, Elmoubasher A ^b   Wang, Lingshu ^c   Lattwein, Erik ^d   Müller, Marcel A ^e   El Zowalaty, Mohamed E ^f   Al Romaihi, Hamad E ^b   Graham, Barney S ^c   Al Thani, Asmaa A ^a   Yassine, Hadi M ^a  

^a QATAR UNIVERSITY   (Qatar)

^b Ministry of Health   (Qatar)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Institute of Experimental Immunology   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; FLU LIKE SYNDROME; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; QATAR; SERODIAGNOSIS; SEROPREVALENCE; SEVERE ACUTE RESPIRATORY SYNDROME; ADOLESCENT; BLOOD; CORONAVIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; POPULATION GROUP; PREVALENCE; RISK; SEROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CORONAVIRUS INFECTIONS; CROSS REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; POPULATION GROUPS; PREVALENCE; QATAR; RISK; SEROLOGY; YOUNG ADULT;

EID: 85062542433     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2019/1386740     Document Type: Article

References (36)

1. WHO, "WHO," 2017, http://www.who.int/emergencies/merscov/ en/.
2. M. G. Hemida, A. Alnaeem, D. K. W. Chu et al., "Longitudinal study of Middle East respiratory syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015," Emerging Microbes &Infections, vol. 6, article e56, 2017.
3. V. S. Raj, E. A. Farag, C. B. Reusken et al., "Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014," Emerging Infectious Diseases, vol. 20, no. 8, pp. 1339-1342, 2014.
4. B. L. Haagmans, S. H. S. al Dhahiry, C. B. E. M. Reusken et al., "Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation," The Lancet Infectious Diseases, vol. 14, no. 2, pp. 140-145, 2014.
5. S. Agnihothram, R. Gopal, B. L. Yount Jr et al., "Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses," The Journal of Infectious Diseases, vol. 209, no. 7, pp. 995-1006, 2014.
6. S. Dea, A. J. Verbeek, and P. Tijssen, "Antigenic and genomic relationships among turkey and bovine enteric coronaviruses," Journal of Virology, vol. 64, no. 6, pp. 3112-3118, 1990.
7. K. H. Chan, J. F. W. Chan, H. Tse et al., "Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests," Journal of Infection, vol. 67, no. 2, pp. 130-140, 2013.
8. V. M. Corman, M. A. Muller, U. Costabel et al., "Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections," Eurosurveillance, vol. 17, no. 49, 2012.
9. V. M. Corman, I. Eckerle, T. Bleicker et al., "Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction," Eurosurveillance, vol. 17, no. 39, 2012.
10. D. Palm, D. Pereyaslov, J. Vaz et al., "Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012," Eurosurveillance, vol. 17, no. 49, 2012.
11. C. Reusken, H. Mou, G. J. Godeke et al., "Specific serology for emerging human coronaviruses by protein microarray," Eurosurveillance, vol. 18, no. 14, 2013.
12. "Laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV)," http://apps.who.int/iris/bitstream /10665/176982/1/WHOMERSLAB15.1eng.pdf?ua=1.
13. "CDC laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV)," http://www.cdc.gov/coronavirus/ mers/lab/lab-testing.html.
14. M. A. Müller, B. Meyer, V. M. Corman et al., "Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study," The Lancet Infectious Diseases, vol. 15, no. 5, pp. 559-564, 2015.
15. C. B. E. M. Reusken, E. A. B. A. Farag, B. L. Haagmans et al., "Occupational exposure to dromedaries and risk for MERS-CoV infection, Qatar, 2013-2014," Emerging Infectious Diseases, vol. 21, no. 8, pp. 1422-1425, 2015.
16. G. K. Nasrallah, S. R. Dargham, L. I. Mohammed, and L. J. Abu-Raddad, "Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in Qatar," Journal of Medical Virology, vol. 90, no. 1, pp. 184-190, 2018.
17. A. A. Al-Qahtani, E. S. Alabsi, R. AbuOdeh, L. Thalib, M. E. El Zowalaty, and G. K. Nasrallah, "Prevalence of anelloviruses (TTV, TTMDV, and TTMV) in healthy blood donors and in patients infected with HBV or HCV in Qatar," Virology Journal, vol. 13, no. 1, p. 208, 2016.
18. R. O. AbuOdeh, E. al-Absi, N. H. Ali et al., "Detection and phylogenetic analysis of human pegivirus (GBV-C) among blood donors and patients infected with hepatitis B virus (HBV) in Qatar," Journal of Medical Virology, vol. 87, no. 12, pp. 2074-2081, 2015.
19. R. AbuOdeh, N. al-Mawlawi, A. A. al-Qahtani et al., "Detection and genotyping of torque teno virus (TTV) in healthy blood donors and patients infected with HBV or HCV in Qatar," Journal of Medical Virology, vol. 87, no. 7, pp. 1184-1191, 2015.
20. M. K. Smatti, H. M. Yassine, R. AbuOdeh et al., "Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar," PLoS One, vol. 12, no. 12, article e0189033, 2017.
21. L. Wang, W. Shi, M. G. Joyce et al., "Evaluation of candidate vaccine approaches for MERS-CoV," Nature Communications, vol. 6, no. 1, p. 7712, 2015.
22. P. T. Afshar and W. H. Wong, "COSINE: non-seeding method for mapping long noisy sequences," Nucleic Acids Research, vol. 45, no. 14, p. e132, 2017.
23. R. S. Sikkema, E. A. B. A. Farag, S. Himatt et al., "Risk factors for primary Middle East respiratory syndrome coronavirus infection in camel workers in Qatar during 2013-2014: a case-control study," The Journal of Infectious Diseases, vol. 215, no. 11, pp. 1702-1705, 2017.
24. K. A. Mohran, E. A. B. A. Farag, C. B. E. M. Reusken et al., "The sample of choice for detecting Middle East respiratory syndrome coronavirus in asymptomatic dromedary camels using real-time reversetranscription polymerase chain reaction," Revue Scientifique et Technique, vol. 35, no. 3, pp. 905-911, 2016.
25. Health KMo, "KSA Ministry of Health," 2017, http://www. moh.gov.sa/en/CCC/PressReleases/Pages/default.aspx.
26. Organization WH, "WHO," 2017, http://www.who.int/csr/ don/27-april-2017-mers-saudi-arabia-and-qatar/en/.
27. P. G. Choe, R. A. P. M. Perera, W. B. Park et al., "MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015," Emerging Infectious Diseases, vol. 23, no. 7, pp. 1079-1084, 2017.
28. J. H. Ko, M. A. Müller, H. Seok et al., "Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity," Diagnostic Microbiology and Infectious Disease, vol. 89, no. 2, pp. 106-111, 2017.
29. C. Drosten, B. Meyer, M. A. Müller et al., "Transmission of MERS-coronavirus in household contacts," The New England Journal of Medicine, vol. 371, pp. 828-835, 2014.
30. J. Pallesen, N. Wang, K. S. Corbett et al., "Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen," Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 35, pp. E7348-E7357, 2017.
31. A. C. Walls, M. A. Tortorici, B. J. Bosch et al., "Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer," Nature, vol. 531, no. 7592, pp. 114-117, 2016.
32. R. N. Kirchdoerfer, C. A. Cottrell, N. Wang et al., "Pre-fusion structure of a human coronavirus spike protein," Nature, vol. 531, no. 7592, pp. 118-121, 2016.
33. W. Song, M. Gui, X. Wang, and Y. Xiang, "Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2," PLoS Pathogens, vol. 14, no. 8, article e1007236, 2018.
34. J. Shang, Y. Zheng, Y. Yang et al., "Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins," PLoS Pathogens, vol. 14, no. 4, article e1007009, 2018.
35. J. Shang, Y. Zheng, Y. Yang et al., "Cryo-electron microscopy structure of porcine deltacoronavirus spike protein in the prefusion state," Journal of Virology, vol. 92, no. 4, 2018.
36. Y. Yuan, D. Cao, Y. Zhang et al., "Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains," Nature Communications, vol. 8, article 15092, 2017.